Catastrophic antiphospholipid syndrome (Ronald Asherson syndrome) and obstetric pathology

References

[1] Antiphospholipid antibodies and thrombotic storm. J. Khizroeva. Proceedings of XIII All-Russian Scientific Forum “Mother and Child”. 2011, pp. 213–4.Suche in Google Scholar

[2] Villa J, Marco A, Santamaria A, Mateo J, Simu M, Constans M, et al. Haemostasis and Thrombosis Unit, Haematology Service. Gynaecology and Obstetrics Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain. 2006. The 2nd International symposium Women’s health issues in thrombosis and Haemostasis. Budapest, Hungary, Feb 4–6, 2005.Suche in Google Scholar

[3] Asherson RA. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson’s) syndrome. Immunobiology. 2005;210:727–33.10.1016/j.imbio.2005.10.002Suche in Google Scholar PubMed

[4] Walsh N. Clinical picture still emerging in CAPS registry. Ob Gyn News. 2006;41:25.Suche in Google Scholar

[5] Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis. 2005;64:1205–9.10.1136/ard.2004.025759Suche in Google Scholar PubMed PubMed Central

[6] The Catastrophic Antiphospholipid Syndrome (Asherson’s Syndrome). Monograph. Collected papers; 1992–2005. Printed by Creda Communications. 112 p.Suche in Google Scholar

[7] Shoenfeld Y. The infectious etiology of APS: novel cross reactive epitopes on yeasts, bacteria and viruses. Immunobiology. 2005;209(Suppl S1). 2^nd Tutzing Antiphospholipid Conference.Suche in Google Scholar

[8] Vora SK, Asherson RA, Erkan D. Catastrophic antiphospholipid syndrome. J Intensive Care Med. 2006;21:144–59.10.1177/0885066606287041Suche in Google Scholar PubMed

[9] Yasuda S, Atsumi T, Matsuura E, Kaihara K, Yamamoto D, Ichikawa K, et al. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant. Arthritis Rheum. 2005;52:212–8.10.1002/art.20741Suche in Google Scholar PubMed

[10] Cervera R. Update on the diagnosis, treatment, and prognosis of the catastrophic antiphosphilipid syndrome. Curr Rheumatol Rep. 2010;12:70–6.10.1007/s11926-009-0073-6Suche in Google Scholar PubMed

[11] Erkan D, Aguiar CL, Andrade D, Cohen H, Cuadrado MJ, Danowski A, et al. 14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev. 2014;13:685–96.10.1016/j.autrev.2014.01.053Suche in Google Scholar PubMed

[12] Asherson RA, Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome – molecular mimicry? J Rheumatol. 2000;27:12–4.Suche in Google Scholar

[13] Gharavi AE, Pierangeli SS, Harris EN. New developments in viral peptides and APL induction. J Autoimmun. 2000;15:227–30.10.1006/jaut.2000.0403Suche in Google Scholar PubMed

[14] Karmochkine M, Mazoyer E, Marcelli A, Boffa MC, Piette JC. High prevalence of antiphospholipid antibodies in DIC. Thromb Haemost. 1996;75:971.10.1055/s-0038-1650403Suche in Google Scholar

[15] Lai S, Walker DH, Elghetany MT. Catastrophic antiphospholipid syndrome: a rare cause of disseminated microvascular thrombotic injury – a case report with pathological and molecular correlative studies. Pathol Int. 2005;55:144–9.10.1111/j.1440-1827.2005.01798.xSuche in Google Scholar PubMed

[16] Makatsariya AD, Bitsadze VO, Dolgushina NV, Yudaeva LS, Khizroeva DH. Antiphospholipid syndrome – immune thrombophilia in obstetrics and gynecology. Moscow. 2007;456s. [M.Triada-X 2007-456s] [In Russian].Suche in Google Scholar

[17] Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med. 2006;34:5–12.10.1515/JPM.2006.001Suche in Google Scholar PubMed

[18] Bernard GR, Vincent JL, Laterre PF, La Rosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Recombinant human protein C. Worldwide Evaluation in Severe Sepsis (PROWESSO study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709.10.1056/NEJM200103083441001Suche in Google Scholar

[19] Ruis-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376:1498–509.10.1016/S0140-6736(10)60709-XSuche in Google Scholar

[20] Kim S, Moskowitz N, Dicarlo E, Bass A, Erkan D, Lockshin M. Catastrophic antiphospholipid syndrome triggered by sepsis. Hosp Special Surg J. 2009;5:67–72.10.1007/s11420-008-9103-6Suche in Google Scholar

[21] Lu CS, Horizon AA, Hwang KK, FitzGerald J, Lin WS, Wallace DJ, et al. Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum. 2005;52:4018–27.10.1002/art.21485Suche in Google Scholar

[22] Carmona F, Lazaro I, Reverter JC, Tassies D, Font J, Cervera R, et al. Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications. Am J Obstet Gynecol. 2006;194:457–65.10.1016/j.ajog.2005.08.059Suche in Google Scholar

[23] Raschi E, Testoni C, Bosisio D, Borghi MO, Koike T, Mantovani A, et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood. 2003;101:3495–500.10.1182/blood-2002-08-2349Suche in Google Scholar

[24] Espinosa G, Bucciarelli S, Cervera R, Lozano M, Reverter J-C, de la Red G . Thrombotic microangiopathic hemolytic anemia and antiphospholipid antibodies. Ann Rheum Dis. 2004;63:730–6.10.1136/ard.2003.007245Suche in Google Scholar

[25] Le Thi Thuong D, Tieulie N, Costedoat N, Andreu MR, Wechsler B. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis. 2005;64:273–8.10.1136/ard.2003.019000Suche in Google Scholar

[26] Kitchens CS. Thrombotic storm: when thrombosis begets thrombosis. Am J Med. 1998;104:381–5.10.1016/S0002-9343(98)00061-8Suche in Google Scholar

[27] Ten Cate H. Pathophysiology of disseminated intravascular coagulation in sepsis. Crit Care Med. 2000;28:9–11.10.1097/00003246-200009001-00003Suche in Google Scholar PubMed

[28] Asherson RA, Espinosa G, Cervera R. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis. 2005;64:943–6.10.1136/ard.2004.026377Suche in Google Scholar PubMed PubMed Central

[29] Katzav A, Evert T, Pick CG, Blank M, Shoenfeld Y, Chapman J. Induction of antiphospholipid syndrome in Factor V Leiden mice. Immunobiology. 2005;209:10–11.Suche in Google Scholar

[30] Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J. LIVE-ENOX Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost. 2005;3:227–9.10.1111/j.1538-7836.2004.01090.xSuche in Google Scholar PubMed

[31] Lockshin MD, Pierangeli SS. Statins for the treatment of obstretic complications in antiphospholipid syndrome? J Reprod Immol. 2010;84:206.10.1016/j.jri.2009.11.007Suche in Google Scholar PubMed

[32] Erkan D, Leibowitz E, Berman J, Lockshin MD. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. J Rheumatol. 2002;29:843–9.Suche in Google Scholar

[33] Sinthiya P, Khamashta MA. Duration of anticoagulation treatment for thrombosis in APS: is it ever safe to stop. Curr Rheumatol Rep. 2013;15:318.10.1007/s11926-013-0318-2Suche in Google Scholar PubMed

[34] Bakshi J, Stevens R. Rituximab therapy for recurrent thromboembolic disease in antiphospholipid syndrome. Lupus. 2013;22:865–7.10.1177/0961203313491023Suche in Google Scholar PubMed

[35] Makatsariya AD, Bitsadze V, Khizroeva JK. Fetal thrombophilia and obstetrics complications. Pathophysiology of haemostasis and thrombosis. Proceeding and abstracts from the 19^th International Congress on Thrombosis. Tel-Aviv, Israel, May 140–18, 2006:A10.Suche in Google Scholar